Persistent colonizing species ratio (0-100): 44.8 Literature
| Butyricimonas virosa| Butyricimonas virosa Sakamoto et al. 2009 emend. Hahnke et al. 2016| Butyricimonas virosa Sakamoto et al. 2009 emend. Sakamoto et al. 2014| CCUG 56611| DSM 23226| JCM 15149| Porphyromonadaceae bacterium JCM 15149| strain MT12
Gut Microbiota: Butyricimonas species are typically found in the human gastrointestinal tract, where they contribute to the complex microbial community.
Butyric Acid Production: Some species within the Butyricimonas genus are known to produce butyric acid through the fermentation of dietary fibers. Butyric acid has been studied for its potential benefits to gut health, including its role as an energy source for colonocytes (cells in the colon) and its anti-inflammatory properties.
Potential Health Benefits: Butyric acid has been associated with various health benefits, including the maintenance of gut barrier function, modulation of the immune system, and potential anti-inflammatory effects. These effects are generally considered beneficial for gut health.
Limited Pathogenicity: Butyricimonas species are not typically associated with pathogenicity. In the context of the gut microbiota, they are considered commensal bacteria, playing a role in maintaining the balance of the microbial community.
Context-Dependent Impact: The health impacts of Butyricimonas virosa, like many bacteria, are likely context-dependent. The overall composition of the gut microbiota, diet, and individual health status can influence the roles of these bacteria in the gut.
The above data is from 1000 Healthy Individuals done using Shotgun(10 Millions reads) provide courtesy of Precision Biome.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
![]() |
NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | Average | Median | Minimum | Maximum | Std.Dev. | Skew | 25 - 75 Percentile | 5 - 95 Percentile | Lab Ranges | Box-Plot-Whiskers | Harmonic Mean | Geometric Mean | Obs. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BiomeSight | 0.4891 | 0.0143 | 0.006 | 0.001 | 0.513 | 0.0293 | 0.8481 | 0.002 - 0.0143 | 0.001 - 0.05 | -0.0429 - 0.0715 | -0.0164 - 0.0326 | 0.0036 | 0.0064 | 1812 |
CosmosId | 0.3143 | 0.2117 | 0.139 | 0.003 | 0.573 | 0.2038 | 1.0702 | 0.0529 - 0.339 | 0.011 - 0.547 | -0.1857 - 0.6091 | -0.3764 - 0.7682 | 0.024 | 0.1026 | 11 |
Medivere | 0.8571 | 0.0304 | 0.0109 | 0.0031 | 0.1065 | 0.0408 | 1.426 | 0.0043 - 0.0392 | 0.0032 - 0.0917 | -0.0493 - 0.11 | -0.0481 - 0.0915 | 0.007 | 0.0133 | 6 |
SequentiaBiotech | 0.1944 | 0.6265 | 0.2564 | 0.0061 | 1.9413 | 0.7485 | 1.4836 | 0.0248 - 1.0662 | 0.0113 - 1.6788 | -0.833 - 2.0861 | -1.5373 - 2.6283 | 0.0279 | 0.1547 | 7 |
Thorne | 0.2011 | 0.0002 | 0.0002 | 0.0001 | 0.0007 | 0.0001 | 0.5324 | 0.0001 - 0.0003 | 0.0001 - 0.0005 | -0.0001 - 0.0005 | -0.0002 - 0.0006 | 0.0002 | 0.0002 | 38 |
Thryve | 0.3944 | 0.0927 | 0.0262 | 0.0001 | 1.0521 | 0.1445 | 1.3803 | 0.0028 - 0.1319 | 0.0011 - 0.3938 | -0.189 - 0.3744 | -0.1908 - 0.3256 | 0.0043 | 0.0213 | 489 |
uBiome | 0.2877 | 0.2663 | 0.1314 | 0.002 | 3.8775 | 0.3806 | 1.0636 | 0.0409 - 0.3713 | 0.0057 - 0.8023 | -0.4758 - 1.0085 | -0.4547 - 0.8669 | 0.0306 | 0.1103 | 227 |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Microba Co-Biome | 0 | 1050 | 0 | 0.105 |
PrecisionBiome | 0.00011293197894701734 | 0.217765212059021 | 0 | 0 |
|
And display level must be raised above public.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]